This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Pulmonary Embolism and Thrombosis
and you are
between 18 and 75
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The objective of the study is to determine the optimum dose of thrombolytic and duration of the ultrasound procedure as a treatment for acute submassive pulmonary embolism.

Provided treatments

  • Device: EkosSonic Endovascular System plus thrombolytic
Tris trial is registered with FDA with number: NCT02396758. The sponsor of the trial is EKOS Corporation and it is looking for 100 volunteers for the current phase.
Official trial title:
Study of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in the Treatment of Acute Submassive Pulmonary Embolism